Abstract:Colorectal cancer (CRC) is a devastating disease, mainly because of metastasis. As a result, there is a need to better understand the molecular basis of invasion and metastasis and to identify new biomarkers and therapeutic targets to aid in managing these tumors. The actin cytoskeleton and actin-binding proteins are known to play an important role in the process of cancer metastasis because they control and execute essential steps in cell motility and contractility as well as cell division. Caldesmon (CaD) is an actin-binding protein encoded by the CALD1 gene as multiple transcripts that mainly encode two protein isoforms: High-molecular-weight CaD, expressed in smooth muscle, and low-molecular weight CaD (l-CaD), expressed in nonsmooth muscle cells. According to our comprehensive review of the literature, CaD, particularly l-CaD, plays a key role in the development, metastasis, and resistance to chemoradiotherapy in colorectal, breast, and urinary bladder cancers and gliomas, among other malignancies. CaD is involved in many aspects of the carcinogenic hallmarks, including epithelial mesenchymal transition via transforming growth factor-beta signaling, angiogenesis, resistance to hormonal therapy, and immune evasion. Recent data show that CaD is expressed in tumor cells as well as in stromal cells, such as cancer-associated fibroblasts, where it modulates the tumor microenvironment to favor the tumor. Interestingly, CaD undergoes selective tumor-specific splicing, and the resulting isoforms are generally not expressed in normal tissues, making these transcripts ideal targets for drug design. In this review, we will analyze these features of CaD with a focus on CRC and show how the currently available data qualify CaD as a potential candidate for targeted therapy in addition to its role in the diagnosis and prognosis of cancer.

The emerging role of CaMKII in cancer.

CAMKIIγ is a Targetable Driver of Multiple Myeloma Through CaMKIIγ/ Stat3 Axis

Regulation of cancer progression by CK2: an emerging therapeutic target

Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.

Role of MARK2 in the nervous system and cancer

The research on expression and mechanism of Ca2+/calmodulin-dependent protein kinaseδin colorectal cancer

CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies

Unveiling the role of CaMKII in retinal degeneration: from biological mechanism to therapeutic strategies

Calcium/Calmodulin-Dependent Protein Kinase II in Cerebrovascular Diseases

A comprehensive review on the dynamics of protein kinase CK2 in cancer development and optimizing therapeutic strategies

The prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer study

Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers

CAMK2γ Antagonizes Mtorc1 Activation During Hepatocarcinogenesis.

Complex roles of cAMP–PKA–CREB signaling in cancer

Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks

CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury

Emerging Roles of ncRNAs Regulating PKM2 in Cancer Progression

Role of TRPM7 kinase in cancer

The Regulatory Roles of Calcium Channels in Tumors

The role of PKM2 in cancer progression and its structural and biological basis

A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention